- Home
- ITT vs EXAS Comparison
ITT vs EXAS Comparison
Compare ITT & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITT
- EXAS
- Stock Information
- Founded
- ITT 1920
- EXAS 1995
- Country
- ITT United States
- EXAS United States
- Employees
- ITT N/A
- EXAS N/A
- Industry
- ITT Fluid Controls
- EXAS Medical Specialities
- Sector
- ITT Industrials
- EXAS Health Care
- Exchange
- ITT Nasdaq
- EXAS Nasdaq
- Market Cap
- ITT 11.7B
- EXAS 10.5B
- IPO Year
- ITT N/A
- EXAS N/A
- Fundamental
- Price
- ITT $153.87
- EXAS $54.26
- Analyst Decision
- ITT Strong Buy
- EXAS Strong Buy
- Analyst Count
- ITT 9
- EXAS 16
- Target Price
- ITT $167.25
- EXAS $72.80
- AVG Volume (30 Days)
- ITT 364.5K
- EXAS 2.2M
- Earning Date
- ITT 02-06-2025
- EXAS 02-19-2025
- Dividend Yield
- ITT 0.83%
- EXAS N/A
- EPS Growth
- ITT 11.49
- EXAS N/A
- EPS
- ITT 5.85
- EXAS N/A
- Revenue
- ITT $3,530,800,000.00
- EXAS $2,692,328,000.00
- Revenue This Year
- ITT $11.76
- EXAS $11.81
- Revenue Next Year
- ITT $7.41
- EXAS $11.52
- P/E Ratio
- ITT $26.36
- EXAS N/A
- Revenue Growth
- ITT 9.36
- EXAS 11.91
- 52 Week Low
- ITT $118.58
- EXAS $40.62
- 52 Week High
- ITT $161.13
- EXAS $79.62
- Technical
- Relative Strength Index (RSI)
- ITT 65.20
- EXAS 43.56
- Support Level
- ITT $137.30
- EXAS $49.79
- Resistance Level
- ITT $145.49
- EXAS $60.88
- Average True Range (ATR)
- ITT 2.73
- EXAS 2.78
- MACD
- ITT 1.50
- EXAS -0.42
- Stochastic Oscillator
- ITT 98.63
- EXAS 40.31
About ITT ITT Inc.
ITT Inc is a diversified manufacturer of engineered critical components and customized technology solutions predominantly for the transportation, industrial and energy markets. The company's products include, brake pads, shock absorbers, pumps, valves, connectors, switches and others. Its operating segments are; Motion Technologies (MT), Industrial Process (IP), and Connect & Control Technologies (CCT). The majority of the revenue is generated from the Motion Technologies segment which is a manufacturer of brake pads, shims, shock absorbers, energy absorption components and sealing technologies. Geographically, the company generates majority of the revenue from North America, and also has its presence in South America, Europe, Asia, Middle East and Africa.
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a precancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.